Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **fungal cell wall synthesis machinery** refers to the collective set of enzymes and multiprotein complexes responsible for building and remodeling the fungal cell wall, which is essential for fungal cell shape, rigidity, and survival. Major components of the wall include β-1,3-glucan, chitin, α-1,3-glucan, mannoproteins, and chitosan, synthesized by transmembrane synthases (like β-1,3-glucan synthase, chitin synthase), transglycosidases, glycosylhydrolases, and accessory proteins. This machinery is absent in humans, making it a prime target for antifungal drug development. Central drug targets within this complex include β-1,3-glucan synthase (targeted by echinocandins) and chitin synthase (targeted experimentally by nikkomycin). The machinery’s disruption impairs structural integrity and leads to fungal cell death, making it crucial for both basic viability and pathogenicity of fungi[1][3][4][5][6].
Inhibition of β-1,3-glucan synthase (echinocandins); Inhibition of chitin synthase (nikkomycin); Interference with glucan biosynthesis (poacic acid)
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fungal cell wall synthesis machinery.